Oxford BioDynamics Plc (OBD.L) LSE

0.48

+0(+0.00%)

Updated at September 29 03:59PM

Currency In GBp

Oxford BioDynamics Plc

Address

3140 Rowan Place

Oxford, OX4 2WB

United Kingdom of Great Britain and Northern Ireland

Phone

44 1865 518 910

Sector

Healthcare

Industry

Biotechnology

Employees

51

First IPO Date

December 06, 2016

Key Executives

NameTitlePayYear Born
Mr. Paul Leslie Stockdale F.C.A., M.A.Chief Financial Officer & Executive Director205,0001975
Dr. Alexandre Akoulitchev M.A., Ma (Oxon), Ph.D.Chief Scientific Officer & Executive Director237,0001962
Mr. Thomas G. Guiel B.A.Chief Operating Officer0N/A
T. DemainCompany Secretary0N/A
David BlumSenior Vice President of Marketing0N/A
Dr. Ewan Hunter B.Sc., Ph.D., Ph.D., (KCL)Chief Data Officer0N/A
Mr. Iain Gladstone Ross B.Sc., BSc (Hons), C.DIR, CH.DExecutive Chairman01954

Description

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures for use in medical testing kits, disease prediction, diagnosis, and treatment. Its products include EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a validated prognostic test for predicting response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling and biomarker discovery. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.